CareLit · DOI-Nachweis · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Dengue vaccine development: status and future
DOI 10.1007/s00103-019-03060-3
Bibliografische Angaben
Nachweis in CareLit
Autor:innenWilder-Smith, A.
ZeitschriftBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Ausgabe1/2020
Jahrgang / SeitenJg. 63 · S. 40 bis 44
Kernaussage aus der Literatur
Abstract-Vorschau
Dengue, the most common arbovirus, represents an increasingly significant cause of morbidity worldwide, including in travelers. After decades of research, the first dengue vaccine was licensed in 2015: CYD-TDV, a tetravalent live attenuated vaccine with a yellow fever vaccine backbone. Recent analyses have shown that vaccine performance is dependent on serostatus. In those who have had a previous dengue infection, i…
Zitieren
Zitierempfehlung
Wilder-Smith, A (2020) Dengue vaccine development: status and future. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 63 (1), 40 bis 44. https://doi.org/10.1007/s00103-019-03060-3
Mit CareLit weiterarbeiten